Type 1 diabetes-a clinical perspective

Lindy Kahanovitz, Patrick M. Sluss, Steven J. Russell

Research output: Contribution to journalArticlepeer-review

73 Scopus citations


Type 1 diabetes mellitus is a disorder of glucose regulation characterized by autoimmune destruction of the insulin-producing pancreatic β-cells and the need for lifelong insulin replacement therapy. Both glucose and HbA1c criteria are available for the diagnosis of diabetes. Achieving and maintaining near-normal blood glucose concentrations with appropriate administration of insulin is critical for successful long-term care of patients with diabetes mellitus and prevention of diabetic complications, but it is very difficult to achieve. Efforts to intensify therapy usually result in hypoglycemia. Point-of-care blood glucose testing provides the information needed by patients for clinical decision-making. Despite the ease of use and rapid reporting of modern point-of-care glucose monitoring devices, they provide measurements only intermittently. Continuous glucose monitoring devices can provide new glucose measurements every 5 minutes and may facilitate better glucose control. The development of new technologies that integrate continuous glucose monitoring technology with insulin pumps and a control algorithm to create a system for automated insulin delivery has the potential to significantly improve glycemic control, reduce hypoglycemia, and reduce the burden of care in type 1 diabetes mellitus.

Original languageEnglish
Pages (from-to)37-40
Number of pages4
JournalPoint of Care
Issue number1
StatePublished - 1 Mar 2017


  • C-peptide
  • Continuous glucose monitoring
  • Hemoglobin A1c
  • Insulin
  • Point-of-care
  • Self-monitoring blood glucose
  • Type 1 diabetes

ASJC Scopus subject areas

  • General Nursing


Dive into the research topics of 'Type 1 diabetes-a clinical perspective'. Together they form a unique fingerprint.

Cite this